Publications

Student Publications

  1. M Degnan, SA Mousa (2020) A narrative review of buprenorphine in adult cancer pain Expert Review of Clinical Pharmacology Sept 21:1-9.
  2. L Salama, ER Pastor, T Stone, SA Mousa (2020) Emerging nanopharmaceuticals and nanonutraceuticals in cancer management Biomedicines 8:347.
  3. SA Sami, NHE Darwish, ANM Barile, SA Mousa (2020) Current and future molecular targets for acute myeloid leukemia therapy Current Treatment Options in Oncology 21:3.
  4. ZI Stryker, M Rajabi, PJ Davis, SA Mousa (2019) Evaluation of angiogenesis assays Biomedicines, 7:Epub 2019/05/19.
  5. ER Pastor, SA Mousa (2019) Current management of neuroblastoma and future direction, Critical Reviews in Oncology Hematology, 138:38-43.
  6. TL Knotts, SA Mousa (2019) Anticoagulation in venous thromboembolism prophylaxis in medically ill patients: Potential impact of NOACs, American Journal of Cardiovascular Drugs Epub Feb 27.
  7. CM Sielaff, SA Mousa (2018) Status and future directions in the management of pancreatic cancer: Potential impact of nanotechnology Journal of Cancer Research and Clinical Oncology 144:1205-1217.
  8. AA Abd-Rabou, DJ Bharali, SA Mousa (2018) Taribavirin and 5-fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking, and antiproliferative effects on MCF-7 breast cancer Pharmaceutical Research 35:76.
  9. MH Elberry, NHE Darwish, SA Mousa (2017) Hepatitis C virus management: Potential impact of nanotechnology Virology Journal 14:88.
  10. P Gladfelter, NHE Darwish, SA Mousa (2017) Current status and future direction in the management of malignant melanoma Melanoma Research 27:403-410.
  11. JW Potts, SA Mousa (2017) Recent advances in management of autosomal-dominant polycystic kidney disease American Journal of  Health System Pharmacy 74:1959-1968.
  12. ZT Sahli, J Jo, SA Mousa, FI Tarazi (2017) Clinical management of restless legs syndrome in end-stage renal disease patients CNS Spectrums 22:14-21.
  13. LA Della Badia, NA Elshourbagy, SA Mousa (2016) Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol Pharmacology & Therapeutics 164:183-194.
  14. SM Brady, L Shapiro, SA Mousa (2016) Current and future direction in the management of scleroderma Archives of Dermatological Research 308:461-471.
  15. BR Yasin, HA El-Fawal, SA Mousa (2015) Date (Phoenix dactylifera) polyphenolics and other bioactive compounds: A traditional islamic remedy’s potential in prevention of cell damage, cancer therapeutics and beyond International Journal of Molecular Sciences 16:30075-30090.
  16. F Tarazi, Z Sahil, J Pleskow, SA Mousa (2015) Asperger’s Syndrome: diagnosis, comorbidity and therapy Expert Review of Neurotherapeutics 15:281-293.
  17. V Belousova, AA Abd-Rabou, SA Mousa (2015) Recent Advances and Future Directions in the Management of Hepatitis C Infections Pharmacology & Therapeutics 145C:92-102.
  18. R Vogel, EA Hussein, SA Mousa (2015) Stem Cells in the Management of Heart Failure: What Have We Learned from Clinical Trials? Expert Review of Cardiovascular Therapy 13:75-83.
  19. DS Bombard, 2nd, SA Mousa (2014) Mayer-Rokitansky-Kuster-Hauser Syndrome: Complications, Diagnosis and Possible Treatment Options: A Review Gynecological Endocrinology 30:618-623.
  20. J Ebright, SA Mousa (2014) Oral Anticoagulants and Status of Antidotes for the Reversal of Bleeding Risk Clinical and Applied Thrombosis/Hemostasis 21:105-114.
  21. FI Tarazi, ZT Sahli, M Wolny, SA Mousa (2014) Emerging Therapies for Parkinson’s Disease: From Bench to Bedside Pharmacology & Therapeutics 144:123-133.
  22. T Sweezy, SA Mousa (2014) Genotype-Guided Use of Oral Antithrombotic Therapy: A Pharmacoeconomic Perspective Personalized Medicine 11:223-235.
  23. M Thomas, SS Mousa, SA Mousa (2013) Comparative Effectiveness of Aflibercept for the Treatment of Patients with Neovascular Age-Related Macular Degeneration Clinical Ophthalmology 7:495-501.
  24. NE Larche, SA Mousa (2013) Riociguat for the Management of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Drugs of Today (Barc) 49:761-768.
  25. T Khushnud, SA Mousa (2013) Potential Role of Naturally Derived Polyphenols and Their Nanotechnology Delivery in Cancer Molecular Biotechnology 55:78-86.
  26. AY Kardys, DJ Bharali, SA Mousa (2013) Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer Journal of Nanotechnology DOI 10.1155/2013/768724.
  27. J Jalaly, J Dalfino, SA Mousa (2013) Onyx(R) in the Management of Cranial Arteriovenous Malformations Expert Review of Medical Devices 10:453-459.
  28. SS Azad, ER Isenovic, S Yaturu, SA Mousa (2013) Insulin Therapy for Diabetes In: Masuo K (ed) Type 2 Diabetes. InTech.
  29. CW Yang, SA Mousa (2012) The Effect of Red Yeast Rice (Monascus Purpureus) in Dyslipidemia and Other Disorders Complementary Therapies in Medicine 20:466-474.
  30. D Swanson, R Block, SA Mousa (2012) Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life Advances in Nutrition 3:1-7.
  31. J Stanekzai, ER Isenovic, SA Mousa (2012) Treatment Options for Diabetes: Potential Role of Stem Cells Diabetes Research and Clinical Practice 98:361-368.
  32. NJ Rogers, SA Mousa (2012) The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome Journal of Alternative and Complementary Medicine 18:112-119.
  33. H Patel, M Qari, SA Mousa (2012) Iron Balance in Β-Thalassemia: Maintaining an Antioxidant / Oxidant Ratio Journal of Applied Hematology 3:4-11.
  34. S Pabani, SA Mousa (2012) Current and Future Treatment of Pulmonary Hypertension Drugs of Today 48:133-147.
  35. JC Keimer, SA Mousa (2012) Expanding the Role of Community Pharmacy: An Evaluation of Generic Drug Discount Programs, Pharmacy Based Immunization Services and Convenient Care Clinics International Journal of Pharmacy 2:1-7.
  36. G Beidoe, SA Mousa (2012) Current Primary Open-Angle Glaucoma Treatments and Future Directions Clinical Ophthalmology 6:1699-1707.
  37. W Aman, S Mousa, G Shiha, SA Mousa (2012) Current Status and Future Directions in the Management of Chronic Hepatitis C Virology Journal 9:57.
  38. J Ramli, P CalderonArtero, RC Block, SA Mousa (2011) Novel Therapeutic Targets for Preserving a Healthy Endothelium: Strategies for Reducing the Risk of Vascular and Cardiovascular Disease Cardiology Journal 18:352-363.
  39. D Laurenzo, SA Mousa (2011) Mechanisms of Drug Resistance in Mycobacterium Tuberculosis and Current Status of Rapid Molecular Diagnostic Testing Acta Tropica 119:5-10.
  40. S Clayton, SA Mousa (2011) Therapeutics Formulated to Target Cancer Stem Cells: Is It in Our Future? Cancer Cell International 11:7.
  41. J-Y Byun, SA Mousa (2011) Thromboprophylaxis in Cancer Patients Receiving Bevacizumab Journal of Applied Hematology 2:273-279.

PRI Staff Publications

  1. Ebtesam A Mohamad, Aya A Aly, Aya A Khalaf, Mona I Ahmed, Reham M Kamel, Sherouk M Abdelnaby, Yasmine H Abdelzaher, Marize G Sedrak, Shaker A Mousa  Evaluation of Natural Bioactive-Derived Punicalagin Niosomes in Skin-Aging Processes Accelerated by Oxidant and Ultraviolet Radiation Drug Des Devel Ther. 2021; 15: 3151–3162. Published online 2021 Jul 17. doi: 10.2147/DDDT.S316247 PMCID:  PMC8311472
  1. Thangirala Sudha 1, Kavitha Godugu 1, Noureldien H. E. Darwish 1,2 , Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin v3 Affinity in Acute Myeloid Leukemia Management    Tipu Nazeer 3 and Shaker A. Mousa 1,* 2021 Aug; 13(16): 4070. Published online 2021 Aug 13. doi: 10.3390/cancers13164070
  2. Uddin MS, Kabir MT, Mamun AA, Sarwar MS, Nasrin F, Emran TB, Alanazi IS, Rauf A, Albadrani GM, Sayed AA, Mousa SA, Abdel-Daim MM.  Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma Front Pharmacol. 2021 Aug 27;12:703761. doi: 10.3389/fphar.2021.703761. eCollection 2021.
  3. Bruce A. Hay, Kavitha Godugu, Noureldien H. E. Darwish, Kazutoshi Fujioka, Thangirala Sudha, Ozlem Ozen Karakus, and Shaker A. Mousa New Thyrointegrin αvβ3 Antagonist with a Scalable Synthesis, Brain Penetration, and Potent Activity against Glioblastoma Multiforme Journal of Medicinal Chemistry 2021 64 (9), 6300-6309 DOI: 10.1021/acs.jmedchem.1c00350
  4. Ozlem Ozen Karakus, Kavitha Godugu, Mehdi Rajabi, and Shaker A. Mousa* Dual Targeting of Norepinephrine Transporter (NET) Function and 2 Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma
    Journal of Medicinal Chemistry 2020 63 (14), 7653-7662 DOI: 10.1021/acs.jmedchem.0c00537
  5. Ozlem Ozen Karakus, Kavitha Godugu, Kazutoshi Fujioka, Shaker A. Mousa Design, synthesis, and biological evaluation of novel bifunctional thyrointegrin antagonists for neuroblastoma   2021 Jul 15;42:116250  doi: 10.1016/j.bmc.2021.116250. Epub 2021 Jun 6.
  6. Ali H El-Far, PhD1 , Kavitha Godugu, PhD2, Ahmed E. Noreldin, PhD1, Amna A. Saddiq, PhD3, Omar A. Almaghrabi, PhD3, Soad K. Al Jaouni, PhD4, and Shaker A. Mousa, PhD, MBA, FACC, FACB2 
    Thymoquinone and Costunolide Induce Apoptosis of Both Proliferative and Doxorubicin-Induced-Senescent Colon and Breast Cancer Cells Integrative Cancer Therapies Volume 20: 1–20 © The Author(s) 2021 DOI: 10.1177/1035450
  7. MS Hamza, SA Mousa. Links between integrin αvβ3 and COVID-19: Impact on vascular and thrombotic risk. In: Bawa R, Audette GF, editors. Current Issues In Medicine: Fundamentals And Basic Medical Sciences: Jenny Stanford Publishing Pte. Ltd.; 2021.
  8. Mohamed ABO, Al-Ama N, Al Kreathy H, Ahmed KHB, Al Amri T, Harakeh S, Mousa SA, De Laat B. Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:966051.
  9. Uddin MS, Kabir MT, Jeandet P, Mathew B, Ashraf GM, Perveen A, Bin-Jumah MN, Mousa SA, Abdel-Daim MM. Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. Oxid Med Cell Longev. 2020 Apr 29;2020:7039138.
  10. Mamun AA, Uddin MS, Bin Bashar MF, Zaman S, Begum Y, Bulbul IJ, Islam MS, Sarwar MS, Mathew B, Amran MS, Md Ashraf G, Bin-Jumah MN, Mousa SA, Abdel-Daim MM. Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease. Oxid Med Cell Longev. 2020 May 15;2020:5086250.
  11. Almuhayawi MS, Ramadan WS, Harakeh S, Al Jaouni SK, Bharali DJ, Mousa SA, Almuhayawi SM. The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model. Saudi J Biol Sci. 2020 Jul;27(7):1710-1716.
  12. Kabir MT, Uddin MS, Zaman S, Begum Y, Ashraf GM, Bin-Jumah MN, Bungau SG, Mousa SA, Abdel-Daim MM. Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease. Mol Neurobiol. 2020 Sep 5. doi: 10.1007/s126-w. Online ahead of print.
  13. Degnan M, Mousa SA. A narrative review of buprenorphine in adult cancer pain. Expert Rev Clin Pharmacol. 2020 Sep 21:1-9.
  14. Khedr S, Klotzsche-von Ameln A, Khedr M, Elsayed MH, Sudha T, Mousa SA, Deussen A, Martin M. Characterization of tryptophan-containing dipeptides for anti-angiogenic effects. Acta Physiol. (Oxf). 2020 Sep:e13556. doi: 10.1111/apha.13556. Online ahead of print.
  15. Iftikhar M, Frey J, Shohan MJ, Malek S, Mousa SA. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy. Pharmacology & Ther. 2020 Oct 29:107719. doi: 10.1016/j.pharmthera.2020.107719.
  16. Mohamed ABO, Al-Ama N, Al Kreathy H, Ahmed KHB, Al Amri T, Harakeh S, Mousa SA, De Laat B. Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism. Clin Appl Thromb Hemost. 2020;26:966051. doi: 10.1177/966051.
  17. Salama L, Pastor ER, Stone T, Mousa SA. Emerging NanoPharmaceuticals and Nanonutraceuticals in Cancer Management. Biomedicines. 2020 Sep 12;8(9):347. doi: 10.3390/biomedicines8090347.
  18. Atta MS, Farrag FA, Almadaly EA, Ghoneim HA, Hafez AS, Al Jaouni SK, Mousa SA, El-Far AH. Transcriptomic and biochemical effects of pycnogenol in ameliorating heat stress-related oxidative alterations in rats. J Therm Biol. 2020 Oct;93:102683. doi: 10.1016/ j.jtherbio.2020.102683.
  19. Neamatallah T, El-Shitany N, Abbas A, Eid BG, Harakeh S, Ali S, Mousa S. Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. Molecules. 2020 Jul 2;25(13):3031. doi: 10.3390/ molecules 25133031.
  20. MM Abo Ghanima, AH Abd El-Aziz, AE Noreldin, MS Atta, SA Mousa, AH El-Far (2020) Beta-glucan administration improves growth performance and gut health in New Zealand White and APRI rabbits with different breed responses PLoS One 15:e0234076.
  21. F Alsayegh, SA Mousa (2020) Challenges in the management of sickle cell disease during SARS-CoV-2 pandemic Clinical and Applied Thrombosis/Hemostasis 26:955240.
  22. MN Boukhatem, A Boumaiza, HG Nada, M Rajabi, SA Mousa (2020) Eucalyptus globulus essential oil as a natural food preservative: Antioxidant, antibacterial and antifungal properties in vitro and in a real food matrix (Orangina fruit juice) Applied Sciences 10:5581.
  23. MN Boukhatem, NHE Darwish, T Sudha, S Bahlouli, D Kellou, AB Benelmouffok, H Chader, M Rajabi, Y Benali, SA Mousa (2020) In vitro antifungal and topical anti-inflammatory properties of essential oil from wild-growing thymus vulgaris (Lamiaceae) used for medicinal purposes in Algeria: A new source of carvacrol Scientia Pharmaceutica 88:33.
  24. MN Boukhatem, MA Ferhat, M Rajabi, SA Mousa (2020) Solvent-free microwave extraction: An eco-friendly and rapid process for green isolation of essential oil from lemongrass Natural Product Research July 24:1-4.
  25. MN Boukhatem, T Sudha, NHE Darwish, H Chader, A Belkadi, M Rajabi, A Houche, F Benkebailli, F Oudjida, SA Mousa (2020) A new eucalyptol-rich lavender (Lavandula stoechas L.) essential oil: Emerging potential for therapy against inflammation and cancer Molecules 25:3671.
  26. PJ Davis, HY Lin, A Hercbergs, KA Keating, SA Mousa (2020) Coronaviruses and integrin αvβ3: Does thyroid hormone modify the relationship? Endocrine Research 45:210-5.
  27. PJ Davis, H-Y Lin, A Hercbergs, SA Mousa (2020) Actions of L-thyroxine (T4) and tetraiodothyroacetic acid (tetrac) on gene expression in thyroid cancer cells Genes 11:755.
  28. PJ Davis, SA Mousa, HY Lin (2020) Nongenomic actions of thyroid hormone: The integrin component Physiological Reviews Jun 25:
  29. PJ Davis, SA Mousa, GP Schechter, HY Lin (2020) Platelet ATP, thyroid hormone receptor on integrin αvβ3 and cancer metastasis Hormones & Cancer 11:13-6.
  30. M Debreli Coskun, T Sudha, DJ Bharali, S Celikler, PJ Davis, SA Mousa (2020) αvβ3 integrin antagonists enhance chemotherapy response in an orthotopic pancreatic cancer model Frontiers in Pharmacology 11:95.
  31. AH El-Far, NHE Darwish, SA Mousa (2020) Senescent colon and breast cancer cells induced by doxorubicin exhibit enhanced sensitivity to curcumin, caffeine, and thymoquinone Integrative Cancer Therapies 19:901160.
  32. AH El-Far, MA Lebda, AE Noreldin, MS Atta, YHA Elewa, M Elfeky, SA Mousa (2020) Quercetin attenuates pancreatic and renal D-galactose-induced aging-related oxidative alterations in rats International Journal of Molecular Sciences 21:4348.
  33. AH El-Far, G Sroga, SKA Jaouni, SA Mousa (2020) Role and mechanisms of RAGE-ligand complexes and RAGE-inhibitors in cancer progression International Journal of Molecular Sciences 21:3613.
  34. AH El-Far, MA Tantawy, SK Al Jaouni, SA Mousa (2020) Thymoquinone-chemotherapeutic combinations: New regimen to combat cancer and cancer stem cells Naunyn-Schmiedeberg’s Archives of Pharmacology 393:1581-98.
  35. K Godugu, AH El-Far, S Al Jaouni, SA Mousa (2020) Nanoformulated Ajwa (Phoenix Dactylifera) bioactive compounds improve the safety of doxorubicin without compromising its anticancer efficacy in breast cancer Molecules (Basel, Switzerland) 25:2597.
  36. MS Hamza, SA Mousa (2020) Cancer-associated thrombosis: Risk factors, molecular mechanisms, future management Clinical and Applied Thrombosis/Hemostasis 26:954282.
  37. S Harakeh, WS Ramadan, MSA Muhayawi, SA Jaouni, S Mousa, KR Hakeem (2020) Pomegranate peel extract lessens histopathologic changes and restores antioxidant homeostasis in the hippocampus of rats with aluminium chloride-induced Alzheimer’s disease Asian Pacific Journal of Tropical Medicine 13:456-63.
  38. A Holub, S Mousa, A Abdolahi, K Godugu, XM Tu, JT Brenna, RC Block (2020) The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus Nutrition, Metabolism and Cardiovascular Diseases 30:1795-9.
  39. OO Karakus, K Godugu, M Rajabi, SA Mousa (2020) Dual targeting of norepinephrine transporter (NET) function and thyrointegrin αvβ3 receptors in the treatment of neuroblastoma Journal of Medicinal Chemistry 63:7653-62.
  40. SA Loutfy, MH Elberry, KY Farroh, HT Mohamed, AA Mohamed, EB Mohamed, AHI Faraag, SA Mousa (2020) Antiviral activity of chitosan nanoparticles encapsulating curcumin against hepatitis C virus genotype 4a in human hepatoma cell lines International Journal of Nanomedicine 15:2699-715.
  41. DS Mousa, AH El-Far, AA Saddiq, T Sudha, SA Mousa (2020) Nanoformulated bioactive compounds derived from different natural products combat pancreatic cancer cell proliferation International Journal of Nanomedicine 15:2259-68.
  42. HG Nada, T Sudha, NHE Darwish, SA Mousa (2020) Lactobacillus acidophilus and bifidobacterium longum exhibit antiproliferation, anti-angiogenesis of gastric and bladder cancer: Impact of COX2 inhibition PharmaNutrition Sept 6:100219.
  43. TA Salaheldin, DJ Bharali, SA Mousa (2020) Functionalized nano-targeted moieties in management of prostate cancer Future Oncology 16:869-83.
  44. A Sallam, SA Mousa (2020) Neurodegenerative diseases and cell reprogramming Molecular Neurobiology Aug 14:
  45. T Sudha, AH El-Far, DS Mousa, SA Mousa (2020) Resveratrol and its nanoformulation attenuate growth and the angiogenesis of xenograft and orthotopic colon cancer models Molecules 25:
  46. AA Alsenosy, AH El-Far, KM Sadek, SA Ibrahim, MS Atta, A Sayed-Ahmed, SK Al Jaouni, SA Mousa (2019) Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats PLoS One 14:e0222410.
  47. A Bridoux, M Samama, S Mousa (2019) Chemical characteristics of direct FXa inhibitors registered for atrial fibrillation Annals of Cardiology and Cardiovascular Medicine 3:1028.
  48. PJ Davis, O Ashur-Fabian, S Incerpi, SA Mousa (2019) Editorial: Non genomic actions of thyroid hormones in cancer Frontiers Endocrinology 10:847.
  49. M Rajabi, K Godugu, T Sudha, DJ Bharali, SA Mousa (2019) Triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol: High affinity thyrointegrin αvβ3 antagonist with potent anticancer activities in glioblastoma multiforme Bioconjugate Chemistry 30:3087-97.
  50. G Shiha, R Soliman, M Elbasiony, NHE Darwish, SA Mousa (2019) Addition of epigallocatechin gallate 400 mg to sofosbuvir 400 mg + daclatisvir 60 mg with or without ribavirin in treatment of patients with chronic hepatitis c improves the safety profile: A pilot study Scientific Reports 9:13593.
  51. M Rajabi, M Adeyeye, SA Mousa (2019) Peptide-conjugated nanoparticles as targeted anti-angiogenesis therapeutic and diagnostic in cancer, Current Medicinal Chemistry, Epub 2019/06/30:
  52. NHE Darwish, T Sudha, K Godugu, DJ Bharali, O Elbaz, HA Abd El-Ghaffar, E Azmy, N Anber, SA Mousa (2019) Novel targeted nano-parthenolide molecule against NF-kB in acute myeloid leukemia, Molecules, 24:Epub 2019/06/06.
  53. WK Li, M Yalcin, DJ Bharali, QS Lin, K Godugu, K Fujioka, KA Keating, SA Mousa (2019) Pharmacokinetics, biodistribution, and anti-angiogenesis efficacy of diamino propane tetraiodothyroacetic acid-conjugated biodegradable polymeric nanoparticle, Scientific Reports, 9:9006.
  54. A Hercbergs, PJ Davis, H-Y Lin, KA Keating, SA Mousa, Thyroid hormone replacement therapy in patients with various types of cancer, In:  Hormone Therapy and Replacement in Cancer and Aging-related Diseases, IntechOpen, 2019.
  55. TA Salaheldin, SA Loutfy, MA Ramadan, T Youssef, SA Mousa (2019) IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model, International Journal of Nanomedicine, 14:4397-4412.
  56. SA Mousa, BM Ayoub (2019) Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents Neural Regeneration Research, 14:745-748.
  57. HY Lin, HY Tang, M Leinung, SA Mousa, A Hercbergs, PJ Davis (2019) Action of reverse T3 on cancer cells Endocrine Research, 1-5.
  58. MA Lebda, WN El-Hawarry, RM Shourbela, AH El-Far, RS Shewita, SA Mousa (2019) Miswak (Salvadora persica) dietary supplementation improves antioxidant status and nonspecific immunity in nile tilapia (Oreochromis niloticus) Fish & Shellfish Immunology, 88:619-626.
  59. N Hamed Anber, AH El-Sebaie, NHE Darwish, SA Mousa, SS Shamaa (2019) Prognostic value of some inflammatory markers in patients with lymphoma Bioscience Reports, 39: Epub March 1.
  60. PJ Davis, HY Lin, AA Hercbergs, KA Keating, SA Mousa (2019) How thyroid hormone works depends upon cell type, receptor type, and hormone analogue: Implications in cancer growth Discovery Medicine, 27:111-117.
  61. BF Cress, U Bhaskar, D Vaidyanathan, A Williams, C Cai, X Liu, L Fu, MC V, F Zhang, SA Mousa, JS Dordick, MAG Koffas, RJ Linhardt (2019) Heavy heparin: A stable isotope-enriched, chemoenzymatically-synthesized, poly-component drug Angewandte Chemie (International ed. in English), Epub March 15.
  62. YT Chin, ZR He, CL Chen, HC Chu, Y Ho, PY Su, YSH Yang, K Wang, YJ Shih, YR Chen, JZ Pedersen, S Incerpi, AW Nana, HY Tang, HY Lin, SA Mousa, PJ Davis, J Whang-Peng (2019) Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status Frontiers in Endocrinology (Lausanne), 10:130.
  63. SK Al Jaouni, A Hussein, N Alghamdi, M Qari, D El Hossary, MS Almuhayawi, D Olwi, R Al-Raddadi, S Harakeh, SA Mousa (2019) Effects of Phoenix dactylifera Ajwa on infection, hospitalization, and survival among pediatric cancer patients in a university hospital: A nonrandomized controlled trial Integrative Cancer Therapies, 18:828834.
  64. M Rajabi, M Yalcin, SA Mousa (2018) Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer Bioorganic & Medicinal Chemistry Letters, 28:1223-1227.
  65. SA Mousa, GV Glinsky, HY Lin, O Ashur-Fabian, A Hercbergs, KA Keating, PJ Davis (2018) Contributions of thyroid hormone to cancer metastasis Biomedicines, 6:89.
  66. HY Lin, SA Mousa, PJ Davis (2018) Demonstration of the receptor site for thyroid hormone on integrin αvβ3 Methods in Molecular Biology, 1801:61-65.
  67. HY Lin, YT Chin, YJ Shih, YR Chen, M Leinung, KA Keating, SA Mousa, PJ Davis (2018) In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic Oncotarget, 9:34033-34037.
  68. JT Leith, SA Mousa, A Hercbergs, HY Lin, PJ Davis (2018) Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone Oncotarget, 9:37069-37075.
  69. JT Leith, A Hercbergs, S Kenney, SA Mousa, PJ Davis (2018) Activation of tumor cell integrin αvβ3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac) Endocrine Research, 43:215-219.
  70. MA Lebda, AH El-Far, AE Noreldin, YHA Elewa, SK Al Jaouni, SA Mousa (2018) Protective effects of miswak (Salvadora persica) against experimentally induced gastric ulcers in rats Oxidative Medicine and Cellular Longevity, 2018:6703296.
  71. AH El-Far, BE Oyinloye, M Sepehrimanesh, MAG Allah, IA Reidah, HM Shaheen, I Razeghian-Jahromi, AEA Alsenosy, AE Noreldin, SK Al Jaouni, SA Mousa (2018) Date palm (Phoenix dactylifera): Novel findings and future directions for food and drug discovery Current Drug Discovery Technologies, Epub March 19.
  72. AH El-Far, SK Al Jaouni, W Li, SA Mousa (2018) Protective roles of thymoquinone nanoformulations: Potential nanonutraceuticals in human diseases Nutrients, 10:1369.
  73. PJ Davis, HY Tang, A Hercbergs, HY Lin, KA Keating, SA Mousa (2018) Bioactivity of thyroid hormone analogs at cancer cells Frontiers in Endocrinology (Lausanne), 9:739.
  74. PJ Davis, SA Mousa, GP Schechter (2018) New interfaces of thyroid hormone actions with blood coagulation and thrombosis Clinical and Applied Thrombosis/Hemostasis, 24:1014-1019.
  75. PJ Davis, SA Mousa, HY Lin (2018) Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense Future Medicinal Chemistry, 10:1637-1639.
  76. JC Chamcheu, IA Siddiqui, VM Adhami, S Esnault, DJ Bharali, AS Babatunde, S Adame, RJ Massey, GS Wood, BJ Longley, SA Mousa, H Mukhtar (2018) Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis International Journal of Nanomedicine, 13:4189-4206.
  77. MS Atta, AH El-Far, FA Farrag, MM Abdel-Daim, SK Al Jaouni, SA Mousa (2018) Thymoquinone attenuates cardiomyopathy in streptozotocin-treated diabetic rats Oxidative Medicine and Cellular Longevity, 2018:7845681.
  78. MM Ardawi, AA Rouzi, NS Al-Senani, MH Qari, AZ Elsamanoudy, SA Mousa (2018) High plasma sphingosine 1-phosphate levels predict osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study Journal of Bone Metabolism, 25:87-98.
  79. AM Abou-El-Naga, G Mutawa, IM El-Sherbiny, SA Mousa (2018) Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells International Journal of Nanomedicine, 13:8153-8164.
  80. MM Abdel-Daim, R Eltaysh, A Hassan, SA Mousa (2018) Lycopene attenuates tulathromycin and diclofenac sodium-induced cardiotoxicity in mice International Journal of Molecular Sciences, 19:344.
  81. E Shinderman-Maman, C Weingarten, D Moskovich, H Werner, A Hercbergs, PJ Davis, M Ellis, O Ashur-Fabian (2018) Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer Molecular Carcinogenesis 57:97-105.
  82. BM Ayoub, S Mowaka, MM Safar, N Ashoush, MG Arafa, HE Michel, MM Tadros, MM Elmazar, SA Mousa (2018) Repositioning of omarigliptin as a once-weekly intranasal anti-parkinsonian agent Science Reports 8:8959.
  83. PJ Davis, JL Leonard, HY Lin, M Leinung, SA Mousa (2018) Molecular basis of nongenomic actions of thyroid hormone In:  G. Litwack (Ed.) Vitamins and Hormones, Academic Press, Chapter 4, pages 67-96.
  84. A Hercbergs, SA Mousa, PJ Davis (2018) Nonthyroidal illness syndrome and thyroid hormone actions at integrin αvβ3 The Journal of Clinical Endocrinology & Metabolism 103:1291-1295.
  85. A Hercbergs, SA Mousa, M Leinung, HY Lin, PJ Davis (2018) Thyroid hormone in the clinic and breast cancer Hormones and Cancer 9:139-143.
  86. AW Nana, YT Chin, CY Lin, Y Ho, JA Bennett, YJ Shih, YR Chen, CA Changou, JZ Pedersen, S Incerpi, LF Liu, J Whang-Peng, E Fu, WS Li, SA Mousa, HY Lin, PJ Davis (2018) Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer Endocrine-Related Cancer 25:279-293.
  87. MJ Martinez-Zapata, AG Mathioudakis, SA Mousa, R Bauersachs (2018) Tinzaparin for long-term treatment of venous thromboembolism in patients with cancer: A systematic review and meta-analysis Clinical and Applied Thrombosis-Hemostasis 24:226-234.
  88. DJ Bharali, T Sudha, H Cui, BM Mian, SA Mousa (2017) Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer Nanomedicine 13:263-273.
  89. L Fu, K Li, D Mori, M Hirakane, L Lin, N Grover, P Datta, Y Yu, J Zhao, F Zhang, M Yalcin, SA Mousa, JS Dordick, RJ Linhardt (2017) Enzymatic generation of highly anticoagulant bovine intestinal heparin Journal of Medicinal Chemistry 60:8673-8679.
  90. MT Hsieh, LM Wang, CA Changou, YT Chin, YSH Yang, HY Lai, SY Lee, YN Yang, J Whang-Peng, LF Liu, HY Lin, SA Mousa, PJ Davis (2017) Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells Oncotarget 8:24237-24249.
  91. JT Leith, PJ Davis, SA Mousa, AA Hercbergs (2017) In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells Cell Cycle 16:367-373.
  92. W Li, M Yalcin, Q Lin, MM Ardawi, SA Mousa (2017) Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery J Control Release, 248:117-124.
  93. V Muralidharan-Chari, J Kim, SA Mousa (2017) Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-L-lysine: A comparative ‘in vitro’ study versus protamine sulfate Thrombosis Research 155:128-130.
  94. S Nallanthighal, C Chan, DJ Bharali, SA Mousa, E Vasquez, R Reliene (2017) Particle coatings but not silver ions mediate genotoxicity of ingested silver nanoparticles in a mouse model NanoImpact 5:92-100.
  95. M Rajabi, SA Mousa (2017) The role of angiogenesis in cancer treatment Biomedicines 5:34.
  96. M Srinivasan, DJ Bharali, T Sudha, M Khedr, I Guest, S Sell, GV Glinsky, SA Mousa (2017) Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation Oncotarget 8:38731-38742.
  97. T Sudha, DJ Bharali, S Sell, NHE Darwish, PJ Davis, SA Mousa (2017) Nanoparticulate tetrac inhibits growth and vascularity of glioblastoma xenografts Hormones and Cancer 8:157-165.
  98. T Sudha, DJ Bharali, M Yalcin, NH Darwish, MD Coskun, KA Keating, HY Lin, PJ Davis, SA Mousa (2017) Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac Nanomedicine (London) 12:195-205.
  99. T Sudha, DJ Bharali, M Yalcin, NH Darwish, M Debreli Coskun, KA Keating, HY Lin, PJ Davis, SA Mousa (2017) Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac International Journal of Nanomedicine 12:1305-1315.
  100. A Abou-ElNaga, G Mutawa, IM El-Sherbiny, H Abd-ElGhaffar, AA Allam, J Ajarem, SA Mousa (2017) Novel nano-therapeutic approach actively targets human ovarian cancer stem cells after xenograft into nude mice  International Journal of Molecular Science 18:813.
  101. BM Ayoub, S Mowaka, ES Elzanfaly, N Ashoush, MM Elmazar, SA Mousa (2017) Pharmacokinetic evaluation of empagliflozin in healthy Egyptian volunteers using LC-MS/MS and comparison with other ethnic populations Science Reports 7:2583.
  102. MS Atta, EA Almadaly, AH El-Far, RM Saleh, DH Assar, SK Al Jaouni, SA Mousa (2017) Thymoquinone defeats diabetes-induced testicular damage in rats targeting antioxidant, inflammatory and aromatase expression International Journal of Molecular Sciences 18(5).
  103. Y-T Chin, L-M Wang, M-T Hsieh, Y-J Shih, AW Nana, CA Changou, Y-CSH Yang, H-C Chiu, E Fu, PJ Davis, H-Y Tang, H-Y Lin (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells Journal of Biomedical Science 24:51.
  104. Y Ho, YS Lin, HL Liu, YJ Shih, SY Lin, A Shih, YT Chin, YR Chen, HY Lin, PJ Davis (2017) Biological mechanisms by which antiproliferative actions of resveratrol are minimized Nutrients 9(10).
  105. MA Abdel-Latif, AH El-Far, AR Elbestawy, R Ghanem, SA Mousa, HS Abd El-Hamid (2017) Exogenous dietary lysozyme improves the growth performance and gut microbiota in broiler chickens targeting the antioxidant and non-specific immunity mRNA expression PLoS One 12:e0185153.
  106. E Block, B Bechand, S Gundala, A Vattekkatte, K Wang, SS Mousa, K Godugu, M Yalcin, SA Mousa (2017) Fluorinated analogs of organosulfur compounds from garlic (allium sativum): Synthesis, chemistry and anti-angiogenesis and antithrombotic studies Molecules 22:2081.
  107. RC Block, A Holub, A Abdolahi, XM Tu, SA Mousa, MN Oda (2017) Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 126:25-31.
  108. NHE Darwish, T Sudha, K Godugu, O Elbaz, HA Abdelghaffar, EEA Hassan, SA Mousa (2016) Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: Potential impact of BMI-1, TIM-3 and CLL-1 Oncotarget 7:57811-57820.
  109. PJ Davis, GV Glinsky, HY Lin, SA Mousa (2016) Actions of thyroid hormone analogues on chemokines Journal of Immunology Research 2016:3147671.
  110. A Hercbergs, PJ Davis, HY Lin, SA Mousa (2016) Possible contributions of thyroid hormone replacement to specific behaviors of cancer Biomedicine & Pharmacotherapy 84:655-659.
  111. HY Lin, YT Chin, AW Nana, YJ Shih, HY Lai, HY Tang, M Leinung, SA Mousa, PJ Davis (2016) Actions of L-thyroxine and nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells Steroids 114:59-67.
  112. V Muralidharan-Chari, J Kim, A Abuawad, M Naeem, HD Cui, SA Mousa (2016) Thymoquinone modulates blood coagulation in vitro via its effects on inflammatory and coagulation pathways International Journal of Molecular Sciences 17:474.
  113. V Muralidharan-Chari, HG Kohan, AG Asimakopoulos, T Sudha, S Sell, K Kannan, M Boroujerdi, PJ Davis, SA Mousa (2016) Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells Oncotarget 7:50365-50379.
  114. V Muralidharan-Chari, SA Mousa (2016) Ciraparantag. Heparin neutralizer anticoagulant reversal agent Drugs of the Future 41:341-346.
  115. M Rajabi, SA Mousa (2016) Lipid nanoparticles and their application in nanomedicine Current Pharmaceutical Biotechnology 17:662-672.
  116. M Rajabi, T Sudha, NHE Darwish, PJ Davis, SA Mousa (2016) Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator Bioorganic & Medicinal Chemistry Letters 26:4112-4116.
  117. YC Yang, YT Chin, MT Hsieh, HY Lai, CC Ke, DR Crawford, OK Lee, E Fu, SA Mousa, P Grasso, LF Liu, HY Chang, HY Tang, HY Lin, PJ Davis (2016) Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin Oncotarget 7:27641-27654.
  118. PJ Davis, T Sudha, HY Lin, SA Mousa (2015) Thyroid hormone, hormone analogs, and angiogenesis Comprehensive Physiology 6:353-362.
  119. HY Lin, GV Glinsky, SA Mousa, PJ Davis (2015) Thyroid hormone and anti-apoptosis in tumor cells Oncotarget 6:14735-14743.
  120. M Rajabi, Z Hossaini, MA Khalilzadeh, S Datta, M Halder, SA Mousa (2015) Synthesis of a new class of furo [3,2-c] coumarins and its anticancer activity Journal of Photochemistry and Photobiology B: Biology 148:66-72.
  121. AM Safer, NA Hanafy, DJ Bharali, HD Cui, SA Mousa (2015) Effect of green tea extract encapsulated into chitosan nanoparticles on hepatic fibrosis collagen fibers assessed by atomic force microscopy in rat hepatic fibrosis model Journal of Nanoscience and Nanotechnology 15:6452-6459.
  122. W Hariri*, T Sudha*, DJ Bharali, H Cui, SA Mousa (2015) Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer Pharmaceutical Research 32:2764-2774. *Contributed equally
  123. A Bani-Jaber, H Cui, A Elsaid, M Yalcin, T Sudha, SA Mousa (2015) Pegylated Solid Lipid Nanoparticles Reconstituted From High-Density Lipoprotein components for Hepatic Targeting Science Letters Journal 4:145.
  124. PJ Davis, GV Glinsky, HY Lin, JT Leith, A Hercbergs, HY Tang, O Ashur-Fabian, S Incerpi, SA Mousa (2015) Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac Frontiers in Endocrinology 5:240.
  125. A Alshaiban, V Muralidharan-Chari, A Nepo, SA Mousa (2015) Modulation of Sickle Red Blood Cell Adhesion and Its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative Clinical and Applied Thrombosis/Hemostasis 22:230-238.
  126. R Alyahya, T Sudha, M Racz, SC Stain, SA Mousa (2015) Anti-Metastasis Efficacy and Safety of Non-Anticoagulant Heparin Derivative Versus Low Molecular Weight Heparin in Surgical Pancreatic Cancer Models Int J Oncol 46:1225-1231
  127. AB Shirode, DJ Bharali, S Nallanthighal, JK Coon, SA Mousa, R Reliene (2015) Nanoencapsulation of Pomegranate Bioactive Compounds for Breast Cancer Chemoprevention International Journal of Nanomedicine 10:475-484.
  128. PJ Davis, HY Lin, T Sudha, M Yalcin, HY Tang, A Hercbergs, JT Leith, MK Luidens, O Ashur-Fabian, S Incerpi, SA Mousa (2014) Nanotetrac Targets Integrin αvβ3 on Tumor Cells to Disorder Cell Defense Pathways and Block Angiogenesis Onco Targets Ther 7:1619-1624.
  129. IA Siddiqui, DJ Bharali, M Nihal, VM Adhami, N Khan, JC Chamcheu, MI Khan, S Shabana, SA Mousa, H Mukhtar (2014) Excellent Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3-Gallate Encapsulated in Chitosan Nanoparticles on Human Melanoma Cell Growth Both in Vitro and in Vivo Nanomedicine 10:1619-1626.
  130. T Sudha, M Yalcin, HY Lin, AM Elmetwally, T Nazeer, T Arumugam, P Phillips, SA Mousa (2014) Suppression of Pancreatic Cancer by Sulfated Non-Anticoagulant Low Molecular Weight Heparin Cancer Letters 350:25-33.
  131. SA Mousa, HY Lin, HY Tang, A Hercbergs, MK Luidens, PJ Davis (2014) Modulation of Angiogenesis by Thyroid Hormone and Hormone Analogues: Implications for Cancer Management Angiogenesis 17:463-469.
  132. N Khan, DJ Bharali, VM Adhami, IA Siddiqui, H Cui, SM Shabana, SA Mousa, H Mukhtar (2014) Oral Administration of Naturally Occurring Chitosan-Based Nanoformulated Green Tea Polyphenol EGCG Effectively Inhibits Prostate Cancer Cell Growth in a Xenograft Model Carcinogenesis 35:415-423.
  133. M Yalcin, HY Lin, T Sudha, DJ Bharali, R Meng, HY Tang, FB Davis, SC Stain, PJ Davis, SA Mousa (2013) Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles Hormones and Cancer 4:176-185.
  134. A Rebbaa, G Patil, M Yalcin, T Sudha, SA Mousa (2013) OT-404, Multi-Targeted Anti-Cancer Agent Affecting Tumor Proliferation, Chemo-Resistance, and Angiogenesis Cancer Letters 332:55-62.
  135. SA Mousa (2013) Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions: Structure-Function Relationship Clinical and Applied Thrombosis/Hemostasis 19:48-54.
  136. AA Lugade, DJ Bharali, V Pradhan, G Elkin, SA Mousa, Y Thanavala (2013) Single Low-Dose Un-Adjuvanted HBsAG Nanoparticle Vaccine Elicits Robust, Durable Immunity Nanomedicine 9:923-934.
  137. HY Lin, YF Su, MT Hsieh, S Lin, R Meng, D London, C Lin, HY Tang, J Hwang, FB Davis, SA Mousa, PJ Davis (2013) Nuclear Monomeric Integrin αv in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone FASEB Journal 27:3209-3216.
  138. PJ Davis, SA Mousa, V Cody, HY Tang, HY Lin (2013) Small Molecule Hormone or Hormone-Like Ligands of Integrin αVβ3: Implications for Cancer Cell Behavior Hormes and Cancer 4:335-342.
  139. PJ Davis, HY Lin, HY Tang, FB Davis, SA Mousa (2013) Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone Thyroid 23:1503-1509.
  140. PJ Davis, GV Glinsky, HY Lin, S Incerpi, FB Davis, SA Mousa, HY Tang, A Hercbergs, MK Luidens (2013) Molecular Mechanisms of Actions of Formulations of the Thyroid Hormone Analogue, Tetrac, on the Inflammatory Response Endocrine Research 38:112-118.
  141. DJ Bharali, M Yalcin, PJ Davis, SA Mousa (2013) Tetraiodothyroacetic Acid-Conjugated Plga Nanoparticles: A Nanomedicine Approach to Treat Drug-Resistant Breast Cancer  Nanomedicine (London) 8:1943-1954.
  142. DJ Bharali, SA Mousa (2013) Relevance of Nanotechnology in Modulating Oxidative Stress: An Overview Methods in Molecular Biology 1028:289-292
  143. DJ Bharali, D Armstrong, SA Mousa (2013) Hybrid Polymeric Nanoparticles: Potential Candidate for Ophthalmic Delivery Methods in Molecular Biology 1028:279-286.
  144. T Sudha, P Phillips, C Kanaan, RJ Linhardt, L Borsig, SA Mousa (2012) Inhibitory Effect of Non-Anticoagulant Heparin (S-Nach) on Pancreatic Cancer Cell Adhesion and Metastasis in Human Umbilical Cord Vessel Segment and in Mouse Model Clin Exp Metastasis 29:431-439
  145. MH Qari, U Dier, SA Mousa (2012) Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients with Sickle Cell Disease Clinical and Applied Thrombosis/Hemostasis 18:195-200
  146. SA Mousa, M Yalcin, DJ Bharali, R Meng, HY Tang, HY Lin, FB Davis, PJ Davis (2012) Tetraiodothyroacetic Acid and Its Nanoformulation Inhibit Thyroid Hormone Stimulation of Non-Small Cell Lung Cancer Cells in Vitro and Its Growth in Xenografts Lung Cancer 76:39-45
  147. SA Mousa (2012) The Future of Anticoagulant Therapy Cardiovascular Therapeutics 30:255-256.
  148. HY Lin, HY Tang, FB Davis, SA Mousa, S Incerpi, MK Luidens, R Meng, PJ Davis (2012) Nongenomic Regulation by Thyroid Hormone of Plasma Membrane Ion and Small Molecule Pumps  Discovery Medicine 14:199-206.
  149. MS Jayaraman, DJ Bharali, T Sudha, SA Mousa (2012) Nano Chitosan Peptide as a Potential Therapeutic Carrier for Retinal Delivery to Treat Age-Related Macular Degeneration Molecular Vision 18:2300-2308.
  150. A Aljada, SA Mousa (2012) Metformin and Neoplasia: Implications and Indications Pharmacology & Therapeutics 133:108-115.